Hong Kong stocks surging | Jiangsu Aidi Pharmaceutical-B (09966.HK) rose by over 4% after announcing that the new drug KN026 had been accepted for listing application by the National Medical Products Administration.
Wise Finance APP learned that Kangning Jer Pharmaceutical-B (09966.HK) rose more than 4%, as of the time of writing, up 4.07% to HK$12.54, with a turnover of HK$43.1641 million.
Latest
